Ranking results:

Past rankings:

2020
Criterium:	Position:
Overall Score:	> 1000
Total Number of Projects:	700-800
2019
Criterium:	Position:
Overall Score:	300-400
Total Number of Projects:	200-300

Ranking timeline:

Project Participation Performance(2019-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 27
As coordinator: 0
As participant: 27
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2022	0	3.260.000	0		1
2021	0	79.422.753	0		6
2020	0	48.298.742	0		5
2019	0	214.067.873	0		15

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
PFIZER LIMITED	19
NOVARTIS PHARMA	18
JANSSEN PHARMACEUTICA NV	13
TAKEDA PHARMACEUTICALS INTERNATIONAL	12
ASTRAZENECA	11
F HOFFMANNLA ROCHE	11
KATHOLIEKE UNIVERSITEIT LEUVEN	10
BAYER	8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	8
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	7
NOVO NORDISK	7
UCB BIOPHARMA	7
ABBVIE INC	6
CHARITE UNIVERSITAETSMEDIZIN BERLIN	6
ELI LILLY AND COMPANY LIMITED	6
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT	6
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	6
KING'S COLLEGE LONDON	6
LEIDS UNIVERSITAIR MEDISCH CENTRUM	6
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN	6
TAKEDA DEVELOPMENT CENTRE EUROPE	6
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	6
ACADEMISCH ZIEKENHUIS GRONINGEN	5
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG	5
LUND UNIVERSITY	5
MERCK SHARP & DOHME CORP	5
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU	5
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	5
UNIVERSITY COLLEGE LONDON	5
UNIVERSITY OF CAMBRIDGE	5
UNIVERSITY OF DUNDEE	5
UPPSALA UNIVERSITET	5
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS	4
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL	4
ELI LILLY AND COMPANY	4
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE	4
FORUM DES PATIENTS EUROPEENS	4
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA	4
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE	4
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS	4
MEDIZINISCHE UNIVERSITAET WIEN	4
STICHTING RADBOUD UNIVERSITEIT	4
TEAM IT RESEARCH SL	4
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA	4
THE UNIVERSITY OF MANCHESTER	4
UNIVERSITA VITASALUTE SAN RAFFAELE	4
UNIVERSITE DU LUXEMBOURG	4
UNIVERSITY OF NEWCASTLE UPON TYNE	4
ACADEMIC MEDICAL CENTRE AMSTERDAM	3
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS	3
AUSTRIAN RESEARCH CENTERS SIEBERDORF	3
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM	3
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL	3
CENTRE DE RECHERCHE PUBLIC DE LA SANTE	3
CENTRE DE REGULACIO GENOMICA	3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V	3
GLAXOSMITHKLINE BIOLOGICALS	3
GOETEBORGS UNIVERSITET	3
JDRF INTERNATIONAL	3
KAROLINSKA INSTITUTE	3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN	3
MEDIZINISCHE HOCHSCHULE HANNOVER	3
MEDIZINISCHE UNIVERSITAT GRAZ	3
STICHTING LYGATURE	3
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM	3
STICHTING VUMC	3
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL	3
THE UNIVERSITY OF SHEFFIELD	3
UNIVERSITA DEGLI STUDI DI FERRARA	3
UNIVERSITA DEGLI STUDI DI SIENA	3
UNIVERSITAET ZUERICH	3
UNIVERSITY COLLEGE DUBLIN	3
UNIVERSITY OF COPENHAGEN	3
UNIVERSITY OF EASTERN FINLAND	3
UNIVERSITY OF OSLO	3
ALLERGAN LIMITED	2
ALZHEIMER EUROPE	2
BRISTOLMYERS SQUIBB COMPANY CORP	2
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY	2
CENTRO DE INVESTIGACION BIOMEDICA EN RED	2
COVANCE LABORATORIES	2
DREEM	2
DRESDEN UNIVERSITY OF TECHNOLOGY	2
EATRIS ERIC	2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK	2
EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING	2
EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS	2
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION	2
FUJIFILM CELLULAR DYNAMICS INC	2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT	2
INSTITUT DE RECHERCHES SERVIER	2
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES	2
ISTITUTO SUPERIORE DI SANITA	2
IXSCIENT LIMITED	2
LONZA	2
LYSOGENE	2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV	2
MCROBERTS BV	2
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY	2

Constancy:

Total number of partners: 854
Partner loyalty:
Frequent Partner: (> 2 projects): 389
Rare Partner: 465
Frequent / Rare Partner Ratio: 0.84

Project overview:

Start date	Project	acronym	role	funding	partners
2022-01-01	FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem	FACILITATE	participant	3.260.000	29
2021-11-01	European platform for neurodegenerative disorders	EPND	participant	9.680.000	29
2021-11-01	Preparing for RSV Immunisation and Surveillance in Europe	PROMISE	participant	3.744.375	22
2021-10-01	Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies	SCREEN4CARE	participant	11.938.569	37
2021-09-01	Innovations to accelerate vaccine development and manufacture	Inno4Vac	participant	18.600.000	41
2021-07-01	Real World Handling of Protein Drugs - Exploration, Evaluation and Education	RealHOPE	participant	3.139.984	27
2021-02-01	Central Repository for Digital Pathology	BIGPICTURE	participant	32.319.825	51
2020-11-01	Accelerating Research & Development for Advanced Therapies	ARDAT	participant	11.773.000	34
2020-10-01	H2O Health Outcomes Observatory	H2O	participant	10.476.687	25
2020-09-01	Prioritisation and Risk Evaluation of Medicines in the EnviRonment	PREMIER	participant	4.550.000	25
2020-05-01	Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA	INNODIA HARVEST	participant	5.999.055	41
2020-01-01	Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies	ImmUniverse	participant	15.500.000	28
2019-12-01	Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies	imSAVAR	participant	10.999.316	28
2019-11-01	Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases	IDEA-FAST	participant	20.997.523	47
2019-11-01	EU Patient- cEntric clinicAl tRial pLatform	EU-PEARL	participant	12.004.953	37
2019-09-01	Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials	Trials@Home	participant	19.036.998	33
2019-09-01	Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions	3TR	participant	40.273.192	70
2019-04-01	Biomarkers in Atopic Dermatitis and Psoriasis	BIOMAP	participant	10.500.000	32
2019-04-01	Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation	ConcePTION	participant	15.299.991	53
2019-04-01	Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement	MOBILISE-D	participant	25.395.897	35
2019-03-01	CARdiomyopathy in type 2 DIAbetes mellitus	CARDIATEAM	participant	6.700.000	21
2019-03-01	Neurotoxicity De-Risking in Preclinical Drug Discovery	NeuroDeRisk	participant	5.331.000	18
2019-03-01	Efficiently Networking European Neurodegeneration Research	NEURONET	participant	1.199.125	10
2019-03-01	Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts	IMMUcan	participant	17.830.000	28
2019-02-01	Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease	TransBioLine	participant	13.999.998	29
2019-01-01	Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain	IM2PACT	participant	9.000.000	27
2019-01-01	Vaccines and Infectious Diseases in the Ageing PopuLation	VITAL	participant	5.499.882	24

Alias institution names:

SANOFIAVENTIS

SANOFI-AVENTIS - France